Seeger Weiss Files Lawsuit on Behalf of Estate of Henrietta Lacks Against Ultragenyx

On August 10th, 2023, the family of Henrietta Lacks, represented by Seeger Weiss partners Chris Seeger and Chris Ayers along with nationally renowned civil rights attorney Ben Crump, filed a lawsuit against Novato, California-based Ultragenyx in the United States District Court for the District of Maryland, alleging the multibillion-dollar biopharmaceutical corporation unjustly enriched itself by […]

August 11, 2023

On August 10th, 2023, the family of Henrietta Lacks, represented by Seeger Weiss partners Chris Seeger and Chris Ayers along with nationally renowned civil rights attorney Ben Crump, filed a lawsuit against Novato, California-based Ultragenyx in the United States District Court for the District of Maryland, alleging the multibillion-dollar biopharmaceutical corporation unjustly enriched itself by profiting from Mrs. Lacks’s genetic material without her family’s consent.

“The enduring legacy of Henrietta Lacks should be one of acknowledgment, respect, and restitution, not continued exploitation by companies like Ultragenyx,” said Seeger. “Their actions stand as a grim reminder of America’s history of medical racism and the urgent need to rectify these past wrongs. Our lawsuit aims to help the Lacks family reclaim their ancestor’s story and receive the justice and compensation they deserve.”

In 1951, Henrietta Lacks was diagnosed with cervical cancer in the racially segregated ward at Johns Hopkins Hospital. Under the guise of cancer treatment, doctors surgically extracted tissue samples from Mrs. Lacks without her knowledge or consent. These stolen cells were cultivated into the first immortal human cell line, known as HeLa cells, and have played a pivotal role in countless pioneering medical discoveries, from the polio vaccine to gene-mapping and in vitro fertilization.

Despite being well aware of the grossly unethical origins of the HeLa cell line, Ultragenyx chose to treat Henrietta Lacks’s body as a manufacturing tool, utilizing her cells as a factory for adeno-associated virus (AAV) vector-based gene therapy products without seeking consent from her family. The company’s continued exploitation of Mrs. Lacks’s stolen cells to reap massive profits denies her and her family basic human dignity.

“Ultragenyx’s decision to profit from Henrietta Lacks’s cells without permission from her family is a glaring example of a biotech company violating ethical boundaries for financial gain,” said Ayers. “Ultragenyx understands—indeed, acknowledges on its own website—that the HeLa cells it cultivates for profit today were stolen from Mrs. Lacks. The company’s business is nothing more than a perpetuation of this theft.”

One of the nation’s preeminent plaintiffs’ law firms, Seeger Weiss is best known for multidistrict mass torts and class actions in both state and federal court. From offices in New York, New Jersey, and Pennsylvania, the firm has represented over 10,000 individuals, organizations, and states and local municipalities across the U.S. that have been injured or defrauded on a massive scale.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More